oncology primary care - md anderson cancer center annual_multidisciplinary... · update in...

APRIL 2-3, 2020The University of Texas MD Anderson Cancer CenterDan L. Duncan Building (CPB), Floor 8, Rooms 1-81155 Pressler StreetHouston, Texas

Annual Multidisciplinary Cancer Care Conference 2020

BRIDGING

Oncology& Primary Care

Educational ObjectivesAfter attending the conference, participants should be able to:

• Utilize new advances, methods and protocols in cancer screening prevention, diagnosis and treatment (Knowledge, Competence, Performance, Patient Outcomes);

• Be equipped with an awareness of the cancer continuum and the place of primary care as well as the resources available for assisting patients through phases of cancer survivorship (Knowledge, Competence, Performance, Patient Outcomes).

Educational MethodsLecture/Didactic – Post Test – Question/Answer Session

Target AudienceThis conference should be of value to Primary Care physicians and hospitalists, medical oncologists, hematologists and surgeons.

EvaluationA course evaluation survey will provide participants with the opportunity to

comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.

Accreditation/Credit DesignationPHYSICIANSThe University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 16.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

EthicsThis course has been designated by The University of Texas MD Anderson Cancer Center for 1.75 AMA PRA Category 1 Credits™ in medical ethics and/or professional responsibility.

FocusThe goal of this conference is to provide primary care physicians, hospitalists, medical oncologists and hematologists evidence based information to enhance medical decision making when managing cancer patients. Physicians need updates on new cancer therapies, current treatment guidelines and resources to assist them in their cancer screening and practice. This activity will address the knowledge gap by bridging oncology with internal medicine, allowing physicians to provide supportive care to cancer patients.


ABIM Maintenance of Certification Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 16 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participant completion data will be shared with and transmitted to the ACCME on the participant’s behalf.

In order to receive MOC points, you must pass the post-test with a score of 70% or higher.

CME Certificates and Attendance Verification CertificatesCertificates awarding AMA PRA Category 1 Credit™ or certificates documenting attendance will be emailed when an individual completes the online CME Verification process after the conference.

MD ANDERSON ORGANIZING COMMITTEE

Mehmet Altan, MD (Chair)Assistant ProfessorHead & Neck/Thoracic Medical Oncology

Ellen Manzullo, MDProfessorGeneral Internal Medicine

Elizabeth Garcia, BSN,MPA,RNAssociate Vice PresidentPatient ExperienceOffice of the Chief Operating Office

Janice Finder, BSN,MSN,RNDirectorPatient Experience Clinical ServicesaskMDAnderson

Elnar KoseogluProgram ManagerPhysician Relations

Yvonne BazunuProgram ManagerPhysician Relations

Allison Baring, CMPCME Conference Planner CME/Conference Management

Bridging Oncology & Primary Care

AgendaThursday, April 27 a.m. Registration and Continental Breakfast

8 a.m. Welcome and Opening Remarks

PRIMARY CARE TRACK MEDICAL ONCOLOGY AND HEMATOLOGY TRACK

8:10 a.m. General Internal Medicine Hospitalist Services at a Comprehensive Cancer Center

Josiah Halm, MD

New Development in Colorectal Cancer Treatment

Arvind Dasari, MBBS

8:45 a.m. Rapid Fire: Care of the Hospitalized Head and Neck Cancer Patient

Michelle Sibille, MD

Pancreatic cancer Moon Shot

Robert A. Wolff, MD

9:20 a.m. Break

9:35 a.m. Rapid Fire: Care of the Hospitalized Lung Cancer Patient

Joanna-Grace Manzano, MD

Immunotherapy for Melanoma

Hussein Tawbi, MD, PhD

10:10 a.m. Rapid Fire: Care of the Hospitalized GI Cancer Patient

David Rubio, MD

Progress and New Approaches in the Treatment of CNS Metastases

Michael A. Davies, MD, PhD

10:55 a.m. Evolving Landscape in Health Care

Brad L. Gibson, MBA

11:30 a.m. Pick up Box Lunch

11:45 a.m. Physician Health & Wellbeing

Alicia Kowalski, MD

12:20 p.m. Immunotherapy Toxicities

Mehmet Altan, MD

1 p.m. Update for Dermatology for Non-Dermatologist

Kelly C. Nelson, MD

HPV Related Head and Neck Cancer

1:35 p.m. Respiratory Viral Infections in Immunocompromised Patients

Roy F. Chemaly, MD

Updates on Treatment of Lung Cancer

George Simon, MD

2:10 p.m. Break


2:25 p.m. Precision Medicine Cancer Genetics

Banu K. Arun, MD

The Other Side of Car T-Cell Therapy: Cytokine Release Syndrome, Neurologic Toxicity and Financial Burden

Elizabeth Shpall, MD

3 p.m. Bone Health in Cancer Patient

Mimi I. Hu, MD

Evolving Practices in Acute Myeloid Leukemia and MDS

Guillermo Garcia-Manero, MD

3:35 p.m. Pre-Op Evaluation for Cancer Patients

Sunil K. Sahai, MD

Updates on Multiple Myeloma

Sheeba K. Thomas, MD

4:10 p.m. Suspicion of Cancer

Gloria Iliescu, MD

Updates on Treatment on Aggressive Non-Hodgkin Lymphoma

Nathan Fowler, MD

4:45 p.m. Smoking Cessation

Maher A. Karam-Hage, MD

State of the Art Update -Chronic Lymphocytic Leukemia

Nitin Jain, MD

5:20 p.m. Closing Remarks and Preview of Friday’s Sessions

5:25 p.m. Adjourn/Reception

Friday, April 3, 20207 a.m. Registration and Continental Breakfast

8 a.m. Welcome and Opening Remarks

PRIMARY CARE TRACK MEDICAL ONCOLOGY AND HEMATOLOGY TRACK

8:10 a.m. Survivorship Issues-Care Planning

Alma Rodriguez, MD

Treatment of Early-Stage Breast Cancer

Meghan S. Karuturi, MD

8:45 a.m. Renal Disorders in Cancer Patients

Farhad R. Danesh, MD

Treatment of Late-Stage Breast Cancer

Bora Lim, MD

9:20 a.m. Break

9:35 a.m. Exercise and Heart Health/Cardio Fit Program

Susan C. Gilchrist, MD

Update in Inflammatory Breast Cancer Treatment

Naoto T. Ueno, MD, PhD

10:10 a.m. Sleep Disorders for Cancer Patients

Dave Balachandran, MD

Updates in Breast Radiation

Melissa P. Mitchell, MD, PhD


10:45 a.m. Care for Geriatric Cancer Patients

Tacara N. Soones, MD

Importance of Accurate Diagnosis in Breast Cancer

Aysegul A. Sahin, MD

11:20 a.m. Pick up Box Lunch

11:35 a.m. Ethics-Patient Coming to ER: Where Do They Need to Go? Palliative Care OR In-Patient?

Ahmed Elsayem, MD

12:10 p.m. Suicide Awareness in Chronic Illness

Alan D. Valentine, MD

12:50 p.m. IgG4 Related Disease for the Primary Care Group; final Title TDB

Jean H. Tayar, MD

Recent Changes in Ovarian Cancer

Robert Coleman, MD

1:25 p.m. How to Use the New Oral Anticoagulants

Michael Kroll, MD

Recent Updates in Uterine Cancer

Michael W. Bevers, MD

2 p.m. Oncologic Emergencies

Jim Yeung, MD

Practice Change Updates in Cervical Cancer

Michael Frumovitz, MD

2:35 p.m. Break

2:45 p.m. Cardiology Issues in Cancer Patients

Nicolas L. Palaskas, MD

Updates in Hereditary Gynecologic Cancers

Karen H. Lu, MD

3:20 p.m. Fecal Transplant

YingHong (Mimi) Wang, MD, PhD

Immunotherapy in GYN Oncology

Amir A. Jazaeri, MD

3:55 p.m. New Drug Development

David Hong, MD

Fertility Issues in Women with Cancer

Terri L. Woodard, MD

4.30 p.m. Closing Remarks


Mehmet Altan, MDAssistant ProfessorThoracic/Head & Neck Med Oncology

Banu K. Arun, MDProfessorBreast Medical Oncology

Dave Balachandran, MDProfessorPulmonary Medicine

Michael W. Bevers, MDProfessorGynecologic Oncology and Reproductive Medicine

Roy F. Chemaly, MDProfessorInfectious Diseases

Robert Coleman, MDProfessorGynecologic Oncology and Reproductive Medicine

Farhad R. Danesh, MDProfessorNephrology

Arvind Dasari, MBBSAssociate ProfessorGastrointestinal Medical Oncology

Michael A. Davies, MD, PhDChairMelanoma Medical Oncology

Ahmed Elsayem, MDProfessorEmergency Medicine

Nathan Fowler, MDProfessorLymphoma/Myeloma

Michael Frumovitz, MDProfessorGynecologic Oncology and Reproductive Medicine

Guillermo Garcia-Manero, MDProfessorLeukemia

Brad L Gibson, MBAVice PresidentRevenue Cycle & TreasurerTreasury Services & Operations

Susan C. Gilchrist, MDAssociate ProfessorClinical Cancer Prevention

Josiah Halm, MDAssociate ProfessorGeneral Internal Medicine

David Hong, MDProfessorInvestigational Cancer Therapeutics

Mimi I. Hu, MDProfessorEndocrine Neoplasia and Hormonal Disorders

Gloria Iliescu, MDAssistant ProfessorGeneral Internal Medicine

Nitin Jain, MDAssociate ProfessorLeukemia

Amir A. Jazaeri, MDProfessorGynecologic Oncology and Reproductive Medicine

Maher A. Karam-Hage, MDProfessorBehavioral Science – Clinical

Meghan S. Karuturi, MDAssistant ProfessorBreast Medical Oncology

Alicia Kowalski, MDProfessorAnesthesiology & PeriOperative Medicine

Michael Kroll, MDProfessorBenign Hematology

Bora Lim, MDAssistant ProfessorBreast Medical Oncology

Karen H. Lu, MDChairGynecologic Oncology and Reproductive Medicine

Joanna-Grace M. Manzano, MDAssistant ProfessorGeneral Internal Medicine

MD Anderson Faculty


Melissa P. Mitchell, MD, PhDAssociate ProfessorRadiation Oncology

Kelly C. Nelson, MDAssociate ProfessorDermatology

Nicolas L. Palaskas, MDAssistant ProfessorCardiology

Alma Rodriguez, MDProfessorLymphoma/Myeloma

David Rubio, MDAssistant ProfessorGeneral Internal Medicine

Sunil K. Sahai, MDProfessorGeneral Internal Medicine

Aysegul A. Sahin, MDProfessorPathology- Anatomical

Michelle M. Sibille, MDAssistant ProfessorGeneral Internal Medicine

Elizabeth Shpall, MDProfessorStem Cell Transplantation

George Simon, MDProfessorThoracic/Head & Neck Med Oncology

Tacara N. Soones, MDAssistant ProfessorGeneral Internal Medicine

Hussein Tawbi, MD, PhDAssociate ProfessorMelanoma Medical Oncology

Jean H. Tayar, MDAssociate ProfessorGeneral Internal Medicine

Sheeba K. Thomas, MDAssociate ProfessorLymphoma/Myeloma

Naoto T. Ueno, MD, PhDProfessorBreast Medical Oncology

Alan D. Valentine, MDChairPsychiatry

YingHong (Mimi) Wang, MD, PhDAssociate ProfessorGastroenterology Hepatology and Nutrition

Robert A. Wolff, MDProfessorGastrointestinal Medical Oncology

Terri L. Woodard, MDAssociate ProfessorGynecologic Oncology and Reproductive Medicine

Jim Yeung, MDProfessorEmergency Medicine


Registration InformationOn-site registration opens at 7:00 am on Friday, February 24. A continental breakfast will be served. The Welcome, Opening Remarks and MOC Pre-Test will begin at 8:00 am and the conference will adjourn at 1:00 pm on Saturday, February 25. Advanced registration is encouraged as space and materials are limited.

The deadline for advanced registration is Friday, February 28, 2020.

There are three ways to register:1. On-line at www.mdanderson.org/conferences2. Fax to: 713-794-17243. Mail to: CME/Conference Management

Unit 1781 The University of Texas MD Anderson Cancer Center P.O. Box 301407 Houston, TX 77230-1407

We accept the following forms of payment:• Check (payable through U.S. banks only)• Money Order• Credit Cards (MasterCard, VISA, and American Express)• Cash (on-site registration only)

A receipt and confirmation letter will be sent to you within ten working days of receipt of your fee. The conference registration fee includes tuition, final conference agenda, continental breakfasts, breaks, and lunch. Please refer to the registration form for specific information regarding fees.

REFUND/CANCELLATION POLICYThe registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before Friday, February 28, 2020. No refunds will be granted after that date. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check.

CME/Conference Management reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, e-mail, or the contact numbers as given on the registration form. In case of activity cancellation, liability of CME/Conference Management is limited to the registration fee. CME/Conference Management will refund the full registration fee.

CME/Conference Management reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available.

For additional information, please contact CME/Conference Management at 713-792-2223 or toll free at 866-849-5866.


SPECIAL ASSISTANCEContact CME/Conference Management at 713-792-2223 or toll-free at 866-849-5866 if you have any special dietary or ADA accommodation needs.

ACCOMMODATIONS• A block of rooms has been reserved for conference attendees at the InterContinental

Houston – Medical Center located at 6750 Main Street, Houston, Texas.• Book your room online at: https://bit.ly/2yoivWB• The hotel phone number is (713) 422-2779.• Early hotel reservation is suggested and the room block cutoff date is Monday,

March 2, 2020.• When you make reservations, be sure to mention the group name: Annual

Multidisciplinary Cancer Care Conference: Bridging Oncology and Primary Care to be assured of receiving the special meeting rate of $179/night for a standard guest room. Please add 17% Texas state and local taxes.

GROUND TRANSPORTATION (prices are subject to change and variable depending on location of conference)

• Houston is served by two airports, George Bush Intercontinental (IAH) and William P. Hobby (HOU). The following forms of ground transportation are available to and from both airports:

– Uber or Lyft – Yellow Cab 713-236-1111

Please let us know what specific topics, issues or questions you wish to see addressed or emphasized in this activity. Fax or e-mail CME/Conference Management. All responses will be forwarded to the Program Chairs for consideration.

The University of Texas MD Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented. MD Anderson also requires that all faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity.

Agendas are subject to change because we are always striving to improve the quality of your educational experience. MD Anderson may substitute faculty with comparable expertise on rare occasions necessitated by illness, schedule conflicts, and so forth.

Photographing, audio taping and videotaping are prohibited.


CO

NFE

REN

CE

REG

ISTR

ATIO

N -

1767

00/3

0/12

1847

/41

An

nu

al M

ult

idis

cip

linar

y C

ance

r C

are

Co

nfe

ren

ce: B

rid

gin

g O

nco

log

y

and

Pri

mar

y C

are

| A

pri

l 2-3

, 202

0

THIS

IS N

OT

A SE

LF-M

AIL

ER -

ADD

RESS

TO

: A

nnua

l Mul

tidis

cipl

inar

y Ca

ncer

Car

e Co

nfer

ence

: Br

idgi

ng O

ncol

ogy

and

Prim

ary

Care

202

0De

part

men

t of C

ME/

Conf

eren

ce M

anag

emen

t – U

nit 1

781

The

Univ

ersi

ty o

f Tex

as M

D A

nder

son

Canc

er C

ente

r PO

Box

301

407,

Hous

ton,

TX

7723

0-14

07or

fax

to 7

13-7

94-1

724

Mak

e ch

eck

or m

oney

ord

er p

ayab

le to

: Th

e Un

iver

sity

of T

exas

MD

And

erso

n Ca

ncer

Cen

ter

REG

ISTR

ATI

ON

FEE

S

Phys

icia

ns

(MD

s/D

Os/

PhD

s)1

Pos

tmar

ked

befo

re F

ebru

ary 2

8 .....

........

........

........

........

.....$

375

1 P

ostm

arke

d af

ter F

ebru

ary 2

8 .....

........

........

........

........

........

$425

Nur

ses

and

Oth

er H

ealt

hca

re P

rofe

ssio

nals

1 P

ostm

arke

d be

fore

Feb

ruar

y 28 .

........

........

........

........

........

..$17

51

Pos

tmar

ked

afte

r Feb

ruar

y 28 .

........

........

........

........

........

....$2

00

MD

AN

DE

RS

ON

REG

IST

RA

TIO

N F

EES

Phys

icia

ns

(MD

s/D

Os/

PhD

s)1

Pos

tmar

ked

befo

re F

ebru

ary 2

8 .....

........

........

........

........

.....$

325

1 P

ostm

arke

d af

ter F

ebru

ary 2

8 .....

........

........

........

........

........

$370

Nur

ses

and

Oth

er H

ealt

hca

re P

rofe

ssio

nals

1 P

ostm

arke

d be

fore

Feb

ruar

y 28 .

........

........

........

........

........

..$12

51

Pos

tmar

ked

afte

r Feb

ruar

y 28 .

........

........

........

........

........

.....$

150

Stu

den

ts/F

ello

ws/

Res

iden

ts1

Pos

tmar

ked

befo

re F

ebru

ary 2

8 .....

........

........

........

........

........

$25

1 P

ostm

arke

d af

ter F

ebru

ary 2

8 .....

........

........

........

........

........

...$50

Last

Nam

eFi

rst

MI

High

est D

egre

e

Depa

rtmen

t (in

clud

e un

it no

.) Sp

ecia

lty

Inst

itutio

n

MD

Ande

rson

Em

ploy

ee ID

No.

(req

uire

d fo

r all

MDA

CC e

mpl

oyee

s):

Phys

icia

n Y

es

No

Stre

et

City

Stat

e/Fo

reig

n Co

untry

/Zip

or M

ail C

ode

Dayt

ime

Phon

e (w

ith a

rea

code

) Ce

ll Ph

one

(with

are

a co

de)

Fax

(with

are

a co

de)

E-m

ail A

ddre

ss (p

leas

e pr

int)

Emer

genc

y Co

ntac

tPh

one

(with

are

a co

de)

Cred

it Ca

rd H

olde

r Nam

e (F

irst/

Last

) Ch

arge

the

follo

win

g: V

ISA

MC

AM

EX

Cred

it Ca

rd N

umbe

rEx

pira

tion

Date

Secu

rity

Code

/CVV

/CSV

Cred

it Ca

rd H

olde

r Bill

ing

Addr

ess

& Z

IP C

ode

MD

And

erso

n In

terd

epar

tmen

tal T

rans

fer (

IDT)

No.

: *Fu

nd G

roup

90

will

not

be

acce

pted

Bus

ines

s U

nit

Dep

artm

ent

Fund

Gro

up*

Fund

Fund

Typ

e

Aut

hori

zed

Sign

atur

e RE

QU

IRED

for C

RED

IT C

ARD

or I

DT

IDT

Appr

over

Nam

e (F

irst/L

ast)

plea

se p

rint

Depa

rtm

ent o

f CM

E/Co

nfer

ence

Man

agem

ent-U

nit 1

781

The

Univ

ersi

ty o

f Tex

as M

D An

ders

on C

ance

r Cen

ter

1767

00/3

0/12

1586

/41

PO B

ox 3

0140

7Ho

usto

n, T

X 77

230-

1407

Non

-Pro

fit O

rg.

U.S.

Pos

tage

P A

I DHo

usto

n, T

XPe

rmit

No.

705

2

oncology primary care - md anderson cancer center annual_multidisciplinary... · update in...

Documents